Drug Watch.
- Published in:
- Formulary, 2012, v. 47, n. 9, p. 342
- Publication type:
- Article
Works matching IS 1082801X AND DT 2012 AND VI 47 AND IP 9
Results: 13
1
2
Former finasteride users with sexual side effects at increased risk for depressive symptoms, suicidal thoughts.
- Published in:
- Formulary, 2012, v. 47, n. 9, p. 341
- By:
- Publication type:
- Article
3
New molecular entities.
- Published in:
- Formulary, 2012, v. 47, n. 9, p. 312
- Publication type:
- Article
4
Pipeline preview.
- Published in:
- Formulary, 2012, v. 47, n. 9, p. 312
- Publication type:
- Article
5
Hip fractures less likely if patients had cataract surgery.
- Published in:
- Formulary, 2012, v. 47, n. 9, p. 311
- By:
- Publication type:
- Article
6
Overprescribing antibiotics in winter months increases antibiotic resistance in community and hospital settings.
- Published in:
- Formulary, 2012, v. 47, n. 9, p. 309
- By:
- Publication type:
- Article
7
Statin use may be linked to increased cataract risk.
- Published in:
- Formulary, 2012, v. 47, n. 9, p. 341
- By:
- Publication type:
- Article
8
Formulary decision process at Mayo Clinic leads to abandoning 80-mg dose of simvastatin.
- Published in:
- 2012
- Publication type:
- Proceeding
9
Targeting the incretin system: Novel advances in the treatment of diabetes.
- Published in:
- Formulary, 2012, v. 47, n. 9, p. 330
- By:
- Publication type:
- Article
10
An evidence-based review of treatment options for irritable bowel syndrome.
- Published in:
- Formulary, 2012, v. 47, n. 9, p. 319
- By:
- Publication type:
- Article
11
Teduglutide: A novel recombinant analog of human glucagon-like peptide-2 for short bowel syndrome.
- Published in:
- Formulary, 2012, v. 47, n. 9, p. 314
- By:
- Publication type:
- Article
12
FDA actions in brief.
- Published in:
- Formulary, 2012, v. 47, n. 9, p. 313
- Publication type:
- Article
13
First-time generic approvals.
- Published in:
- Formulary, 2012, v. 47, n. 9, p. 313
- Publication type:
- Article